These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Noncompliance with immunnosuppressive medications after renal transplantation. Ghods AJ; Nasrollahzadeh D Exp Clin Transplant; 2003 Jun; 1(1):39-47. PubMed ID: 15859906 [TBL] [Abstract][Full Text] [Related]
3. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508 [TBL] [Abstract][Full Text] [Related]
4. Correlates of noncompliance among renal transplant recipients. Frazier PA; Davis-Ali SH; Dahl KE Clin Transplant; 1994 Dec; 8(6):550-7. PubMed ID: 7865918 [TBL] [Abstract][Full Text] [Related]
5. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant. Elmagd MM; Bakr MA; Metwally AH; Wahab AM Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244 [TBL] [Abstract][Full Text] [Related]
6. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. De Geest S; Abraham I; Moons P; Vandeputte M; Van Cleemput J; Evers G; Daenen W; Vanhaecke J J Heart Lung Transplant; 1998 Sep; 17(9):854-63. PubMed ID: 9773856 [TBL] [Abstract][Full Text] [Related]
7. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression. Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704 [TBL] [Abstract][Full Text] [Related]
8. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens. DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069 [TBL] [Abstract][Full Text] [Related]
9. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors. Bajjoka I; Hsaiky L; Brown K; Abouljoud M Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842 [TBL] [Abstract][Full Text] [Related]
10. Factors contributing to acute rejection in renal transplantation: the role of noncompliance. Morrissey PE; Reinert S; Yango A; Gautam A; Monaco A; Gohh R Transplant Proc; 2005 Jun; 37(5):2044-7. PubMed ID: 15964334 [TBL] [Abstract][Full Text] [Related]
11. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. De Geest S; Borgermans L; Gemoets H; Abraham I; Vlaminck H; Evers G; Vanrenterghem Y Transplantation; 1995 Feb; 59(3):340-7. PubMed ID: 7871562 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation. Harmon W; Meyers K; Ingelfinger J; McDonald R; McIntosh M; Ho M; Spaneas L; Palmer JA; Hawk M; Geehan C; Tinckam K; Hancock WW; Sayegh MH J Am Soc Nephrol; 2006 Jun; 17(6):1735-45. PubMed ID: 16687625 [TBL] [Abstract][Full Text] [Related]
13. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival. Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959 [TBL] [Abstract][Full Text] [Related]
14. Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation. Loghman-Adham M Am J Manag Care; 2003 Feb; 9(2):155-71. PubMed ID: 12597603 [TBL] [Abstract][Full Text] [Related]
15. Medication compliance among renal transplant patients: a Hospital Kuala Lumpur experience. Liu WJ; Zaki M Med J Malaysia; 2004 Dec; 59(5):649-58. PubMed ID: 15889568 [TBL] [Abstract][Full Text] [Related]
16. Renal graft outcome in simultaneous kidney transplantation combined with other organs: experience of a single center. Gutierrez-Baños J; Portillo J; Ballestero R; Zubillaga S; Ramos E; Campos J; Hidalgo E Transplant Proc; 2008 Dec; 40(10):3424-7. PubMed ID: 19100404 [TBL] [Abstract][Full Text] [Related]
17. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation. Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447 [TBL] [Abstract][Full Text] [Related]
18. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation. Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564 [TBL] [Abstract][Full Text] [Related]
19. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109 [TBL] [Abstract][Full Text] [Related]
20. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors? Nashan B Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]